Aug 2026· Research· Vol 9· 0 citations· 43 references
Medicine
TL;DR
Mirror-Peptidizer is reported, an end-to-end in silico mirror-image screening workflow that generates D-peptide binders without requiring chemical synthesis of D-protein targets.
Abstract
D-peptides are attractive therapeutic modalities because they are generally more resistant to proteolysis than their L-counterparts, yet systematic design of target-binding D-peptides remains nontrivial. Here, we report Mirror-Peptidizer, an end-to-end in silico mirror-image screening workflow that generates D-peptide binders without requiring chemical synthesis of D-protein targets. The workflow mirrors an L-protein structure to a virtual D-protein, designs L-peptide backbones in the presence of the mirrored target using a diffusion-based backbone generator, selects sequences with a neural sequence design model, and explores local sequence neighborhoods via Bayesian multi-objective optimization balancing sequence-backbone compatibility and a solubility heuristic. Mirroring the resulting complex yields the corresponding D-peptide predicted to bind the native L-target. Using MDM2, PD-L1, and interleukin-23 receptor (IL-23R) as test cases, we identified D-peptides spanning α-helical, β-rich, and mixed conformations with affinity from 11.9 nM to sub-μM. For the MDM2 system, the 1H-15N HSQC (heteronuclear single quantum coherence) perturbations and protein mutagenesis support the designed interface, and cell-penetrating conjugates show p53-dependent cancer growth inhibition. Similarly, PD-L1-targeting D-peptides potently inhibited PD-1/PD-L1 interactions in competitive binding assays in vitro, and IL-23R-targeting D-peptides inhibited IL-2/IL-12/IL-23-induced interferon-γ production in human peripheral blood mononuclear cells. Mirror-Peptidizer is provided as an open-source implementation to facilitate rapid generation of experimentally testable D-peptide starting points.
D-peptides combine protease resistance with high target specificity, but computational design of D-peptide binders remains immature. Mirror-Peptidizer introduced an in silico mirror-image screening pipeline using target reflection, backbone generation, and ProteinMPNN sequence design, but its raw ProteinMPNN negative l...
HighMorph is presented, an interaction-guided framework that combines protein–protein interaction information with artificial intelligence for rational cyclic peptide design and provides insights for developing therapeutics targeting challenging protein interfaces.
M. Lan, Cheng-Yun Zhang, Wentong Wang et al.· Journal of Medicinal Chemist...· 0 citations
Intrinsically disordered proteins, topologically complex protein surfaces, and biomolecular condensates regulate essential cellular processes but remain difficult to drug with conventional small molecules. Here, we present PepSpace, a physics-driven directed-evolution platform coupling residue-resolution coarse-grained...
J. Oller-Iscar, A. Tejedor, A. Feito et al.· bioRxiv· 0 citations
The REceptor-Aware Peptide Sequence Designer (REAPS), a geometric graph neural network that reframes sequence design for peptide binders by treating the receptor as a fully observable all-atom context, is introduced.
Yong-Kang Qiu, Jing-Xin Qiao, Leng-Jing Zhu et al.· Journal of Chemical Informat...· 0 citations
Peptide lasso-grafting strategies enable the transfer of established pharmacophores into compact protein scaffolds but often require optimization to preserve target binding and biological activity. Here, we report Random in-vitro Protein single-Loop Engineering (RiPLE), an mRNA-display strategy for the direct discovery...
Kilian Colas, T. Ko, G. Philippe et al.· bioRxiv· 0 citations
Assistant Professor Benjamin Lindquist studies how engineers deliberately injected randomness into early AI, giving rise to deep-learning models that sometimes hallucinate.
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.